With a rapper’s death, harsh spotlight falls on slow progress against sickle cell
Other genetic disorders have attracted piles of money that have helped lead to cures, but sickle cell has historically been starved for funds.
by Sharon Begley
Jun 21, 2017
4 minutes
The death of the rap artist Prodigy (Albert Johnson, half of the duo Mobb Deep) at only 42 this week, after a lifetime of suffering from sickle cell disease, was a reminder of the devastating cost of the sometimes fatal genetic disorder — and of the failure to cure it.
It has been 61 years since the of the mutation responsible for sickle cell, which affects about 100,000 people in the U.S., and 30 years since scientists found a compensatory mutation — one that keeps people from developing sickle cell despite inheriting the mutant genes. Last year, when STAT the lack of progress, scientists
You’re reading a preview, subscribe to read more.
Start your free 30 days